Latisse®

Take your lashes to the next level with the only FDA-approved treatment for not enough or thinning lashes.
Week0-16
LATISSE® works by lengthening the growth phase of the lashes and is clinically proven in 16 weeks to increase their growth, including length, thickness, and darkness.

For more info on LATISSE®
How to apply
What to expect
FAQs

IMPORTANT SAFETY INFORMATION

Contraindications: LATISSE® is contraindicated in patients with hypersensitivity to bimatoprost or to any of the ingredients.

Warnings and Precautions: In patients using LUMIGAN® (bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use of LATISSE® may interfere with the desired reduction in IOP. Patients using prostaglandin analogs including LUMIGAN® for IOP reduction should only use LATISSE® after consulting with their physician and should be monitored for changes to their intraocular pressure.

Increased iris pigmentation has occurred when bimatoprost solution was administered. Patients should be advised about the potential for increased brown iris pigmentation, which is likely to be permanent.

Bimatoprost has been reported to cause pigment changes (darkening) to periorbital pigmented tissues and eyelashes. The pigmentation is expected to increase as long as bimatoprost is administered, but has been reported to be reversible upon discontinuation of bimatoprost in most patients.

There is the potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with skin surfaces. Apply LATISSE®only to the skin of the upper eyelid margin at the base of the eyelashes.

LATISSE® solution should be used with caution in patients with active intraocular inflammation (eg, uveitis) because the inflammation may be exacerbated. LATISSE® should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema.

Adverse Reactions: The most frequently reported adverse reactions were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and periorbital erythema. These reactions occurred in less than 4% of patients.

Postmarketing Experience: The following adverse reactions have been identified during postapproval use of LATISSE®: dry skin of the eyelid and/or periocular area, eye swelling, eyelid edema, hypersensitivity (local allergic reactions), lacrimation increased, madarosis and trichorrhexis (temporary loss of a few eyelashes to loss of sections of eyelashes, and temporary eyelash breakage, respectively), periorbital and lid changes associated with a deepening of the eyelid sulcus, rash (including macular and erythematous), skin discoloration (periorbital), and vision blurred.

Schedule an Appointment

We’re here when you need us. Schedule appointments easily to fit your busy lifestyle.

Call 605-271-2210

Obstetric Care

In addition to routine obstetric care, we specialize in the management of high risk pregnancy complications such as hypertension, diabetes and advanced maternal age.

Gynecologic Care

We have a special interest in pelvic pain, infertility, abnormal bleeding, and abnormal pap smears. We provide numerous procedures in our office, including ultrasounds, LEEPs, Cryotherapy and colposcopies.

Gynecologic Surgery

We offer definitive surgeries including hysterectomy, bladder repairs and tubal ligations. Ideally, the least invasive approach is used such as outpatient laparoscopy, hysteroscopy, and endometrial ablation.

Latisse

Take your lashes to the next level using the only FDA approved LATISSE® treatment for not enough or thinning lashes!